These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2843321)

  • 21. High frequency of autoantibodies bearing cross-reactive idiotopes among hybridomas using VH7183 genes prepared from normal and autoimmune murine strains.
    Bellon B; Manheimer-Lory A; Monestier M; Moran T; Dimitriu-Bona A; Alt F; Bona C
    J Clin Invest; 1987 Apr; 79(4):1044-53. PubMed ID: 3558816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The production of human-hybridomas and its contribution to the autoimmune diseases].
    Shoenfeld Y
    Harefuah; 1984 Sep; 107(5-6):134-5. PubMed ID: 6510820
    [No Abstract]   [Full Text] [Related]  

  • 23. B and T cells are not required for the viable motheaten phenotype.
    Yu CC; Tsui HW; Ngan BY; Shulman MJ; Wu GE; Tsui FW
    J Exp Med; 1996 Feb; 183(2):371-80. PubMed ID: 8627150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased expression of the stefin A cysteine proteinase inhibitor occurs in the myelomonocytic cell-infiltrated tissues of autoimmune motheaten mice.
    Mlinaric-Rascan I; Asa SL; Siminovitch KA
    Am J Pathol; 1994 Oct; 145(4):902-12. PubMed ID: 7943179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of hybridomas to analyse autoimmunity.
    Isenberg DA; Shoenfeld Y; Schwartz RS
    Br Med Bull; 1984 Jul; 40(3):262-6. PubMed ID: 6380637
    [No Abstract]   [Full Text] [Related]  

  • 26. Both Sm and DNA are selecting antigens in the anti-Sm B cell response in autoimmune MRL/lpr mice.
    Retter MW; Cohen PL; Eisenberg RA; Clarke SH
    J Immunol; 1996 Feb; 156(3):1296-306. PubMed ID: 8558010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppressive effects of monocytic cells and transforming growth factor-beta on natural killer cell differentiation in autoimmune viable motheaten mutant mice.
    Koo GC; Manyak CL; Dasch J; Ellingsworth L; Shultz LD
    J Immunol; 1991 Aug; 147(4):1194-200. PubMed ID: 1714475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T cells specific for DNA-binding peptides.
    Wang M; Desai D; Marion TN
    Lupus; 1997; 6(3):349-50. PubMed ID: 9296788
    [No Abstract]   [Full Text] [Related]  

  • 29. DNA antibodies focus on the light chain.
    Diamond B; Eilat D
    Lupus; 1997; 6(3):315-6. PubMed ID: 9296775
    [No Abstract]   [Full Text] [Related]  

  • 30. DNA-binding antibodies from viable motheaten mutant mice: implications for B cell tolerance.
    Westhoff CM; Whittier A; Kathol S; McHugh J; Zajicek C; Shultz LD; Wylie DE
    J Immunol; 1997 Sep; 159(6):3024-33. PubMed ID: 9300728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Mott cell hybridoma.
    Weiss S; Burrows PD; Meyer J; Wabl MR
    Eur J Immunol; 1984 Aug; 14(8):744-8. PubMed ID: 6432555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of autoreactive T-cell hybridomas from autoimmune model mice.
    Yanoma S; Aoki I; Ishii N; Tani K; David CS; Okuda K
    Immunology; 1988 May; 64(1):113-9. PubMed ID: 3260213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A murine hybridoma with large cytoplasmic inclusions of kappa light chains.
    Reason DC
    J Exp Med; 1987 Feb; 165(2):578-83. PubMed ID: 3029271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High level expression of the plasma cell antigen PC.1 on the T-cell subset expanding in MRL/MpJ-lpr/lpr mice: detection with a xenogeneic monoclonal antibody and alloantisera.
    Dumont FJ; Habbersett RC; Coker LZ; Nichols EA; Treffinger JA
    Cell Immunol; 1985 Dec; 96(2):327-37. PubMed ID: 2943419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased yields of IgG2a- and IgG3-secreting hybridomas after fusion of B cells from mice with autoimmune diseases.
    Yin BW; Wong GY; Lloyd KO; Oettgen HF; Welt S
    J Immunol Methods; 1991 Nov; 144(2):165-73. PubMed ID: 1960413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoimmune MRL mice express high-affinity IgG2b monoclonal autoantibodies to heparin.
    Fillit H; Edstrom W; Yang CP; Moran T; Dimitriu-Bona A
    Clin Immunol Immunopathol; 1996 Oct; 81(1):62-7. PubMed ID: 8808643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional consequences of the SHP-1 defect in motheaten viable mice: role of NF-kappa B.
    Khaled AR; Butfiloski EJ; Sobel ES; Schiffenbauer J
    Cell Immunol; 1998 Apr; 185(1):49-58. PubMed ID: 9636682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Defective lymphopoiesis in bone marrow of motheaten (me/me) and viable motheaten (mev/mev) mutant mice. I. Analysis of development of prothymocytes, early B lineage cells, and terminal deoxynucleotidyl transferase-positive cells.
    Greiner DL; Goldschneider I; Komschlies KL; Medlock ES; Bollum FJ; Schultz L
    J Exp Med; 1986 Oct; 164(4):1129-44. PubMed ID: 3531380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Germline V genes encode viable motheaten mouse autoantibodies against thymocytes and red blood cells.
    Kasturi KN; Mayer R; Bona CA; Scott VE; Sidman CL
    J Immunol; 1990 Oct; 145(7):2304-11. PubMed ID: 2118932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ets-1 deficiency leads to altered B cell differentiation, hyperresponsiveness to TLR9 and autoimmune disease.
    Wang D; John SA; Clements JL; Percy DH; Barton KP; Garrett-Sinha LA
    Int Immunol; 2005 Sep; 17(9):1179-91. PubMed ID: 16051621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.